🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ana C. Garrido-Castro

Harvard University

ORCID: 0000-0002-5989-6636

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.4Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Papers

Driven by 11 papers — median percentile 91. Top paper: “Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group”.

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2
N/A
3.5DataRank · unranked
168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01354-y
N/A
3.0DataRank · unranked
148 citations

Cristina Saura, Romualdo Barroso‐Sousa, Hao Guo, Eva Ciruelos, Begoña Bermejo +18 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Genomic profiling of breast cancer brain metastases reveals targetable alterations.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2525
N/A
0.104DataRank · unranked
1 citations

Liam F. Spurr, Melissa E. Hughes, Yvonne Y. Li, José Pablo Leone, Ana C. Garrido-Castro +8 more

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

ESMO Open(2024)10.1016/j.esmoop.2024.103973
N/A
0DataRank · unranked
12 citations

Danielle Brandes Zakon, Qingchun Jin, Ava Strahan, Melissa Grimm, Melissa E. Hughes +15 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

UNC Libraries(2024)10.17615/m9ck-zv98
N/A
0DataRank · unranked
0 citations

Jonathan C. Silverstein, AURORA US Network, Melina E Sanders, P.W. Laird, C.M. Perou +53 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430
N/A
0DataRank · unranked
14 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy

ESMO Open(2025)10.1016/j.esmoop.2025.105568
N/A
0DataRank · unranked
1 citations

Qi Jin, Agepati S. Raghavendra, Danielle Brandes Zakon, Melissa Grimm, Melissa E. Hughes +16 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685
N/A
0DataRank · unranked
60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1
N/A
0DataRank · unranked
2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer

The Journal of Experimental Medicine(2023)10.1084/jem.20220729
N/A
0DataRank · unranked
34 citations

Ana C. Garrido-Castro, Patrick J. Lenehan, Naïma Böllenrücher, Courtney T. Stump, Michael Dougan +5 more